Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
KBSX - FST Corp - Stock Price Chart
TickerKBSX [NASD]
CompanyFST Corp
CountrySingapore
IndustrySteel
Market Cap37.25MEPS (ttm)-0.55
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.96EPS Q/Q-72.77%
Dividend-Sales Q/Q-
Insider Own47.90%Inst Own44.98%
Insider Trans0.00%Inst Trans1.74%
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume1.10M52W Range1.26 - 15.48
INDP - Indaptus Therapeutics Inc - Stock Price Chart
TickerINDP [NASD]
CompanyIndaptus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap11.69MEPS (ttm)-1.72
P/E-EPS this Y50.93%
Forward P/E-EPS next Y20.25%
PEG-EPS past 5Y56.03%
P/S-EPS next 5Y26.86%
P/B1.38EPS Q/Q30.88%
Dividend-Sales Q/Q-
Insider Own19.56%Inst Own14.20%
Insider Trans0.00%Inst Trans1.44%
Short Float0.50%EarningsMar 13/b
Analyst Recom1.00Target Price5.00
Avg Volume329.13K52W Range0.70 - 3.10
Mar-18-25 08:00AM Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab (GlobeNewswire)
Mar-13-25 07:30AM Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-12-25 04:15PM Registration Is Now Open For Tribe Public's Webinar Event Keys To The Kingdom: Unlocking The Power Of Your Immune System Featuring Indaptus Therapeutics' CEO On Monday, March 17, 2025 (GlobeNewswire)
Mar-04-25 08:00AM Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments (GlobeNewswire)
Feb-25-25 08:00AM Indaptus Therapeutics' Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit (GlobeNewswire)
Feb-05-25 08:00AM Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20 (GlobeNewswire) -9.49%
Jan-13-25 08:00AM Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Jan-08-25 08:00AM Indaptus Therapeutics Provides Year-End Review and Outlook for 2025 (GlobeNewswire)
Nov-22-24 08:36AM Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Nov-12-24 08:00AM Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
ABLD - Abacus FCF Real Assets Leaders ETF - Stock Price Chart
TickerABLD [AMEX]
CompanyAbacus FCF Real Assets Leaders ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
IndexAbacus FCF Real Assets Leaders Index
Asset TypeEquities (Stocks)ETF TypeUS Equities
Sector/Theme Region
Dividend9.29%Active/Passive
Total Holdings51AUM6.44M
Flows% 1M-9.82%Flows% 3M-74.00%
Flows% YTD-9.82%Flows% 1Y
Return% 1Y-1.38%Return% 3Y0.07%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume29.23K52W Range27.65 - 32.84
ADTX - Aditxt Inc - Stock Price Chart
TickerADTX [NASD]
CompanyAditxt Inc
CountryUSA
IndustryBiotechnology
Market Cap7.73MEPS (ttm)-245412.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y45.26%
P/S36.81EPS next 5Y-
P/B0.00EPS Q/Q94.31%
Dividend-Sales Q/Q-94.49%
Insider Own-Inst Own24.59%
Insider Trans-Inst Trans0.07%
Short Float-Earnings-
Analyst Recom1.00Target Price610000.00
Avg Volume1.92M52W Range4.11 - 54500.00
Mar-18-25 07:22AM Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update (GlobeNewswire) +71.62%
Mar-17-25 08:15AM Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 (Business Wire) -13.03%
Mar-12-25 04:15PM Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 (Business Wire) -5.33% -41.20%
Mar-06-25 08:15AM Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S. (Business Wire) -13.30%
Feb-22-25 08:45AM Aditxt subsidiary Persanta engages Dominary Securities for IPO (TipRanks)
Feb-21-25 08:15AM Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025 (Business Wire) -22.98%
Feb-13-25 08:15AM Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time (Business Wire) -17.87%
Jan-13-25 08:15AM Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform (Business Wire) -8.24%
Dec-12-24 08:15AM Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials (Business Wire)
Nov-19-24 07:17AM Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. (GlobeNewswire)
TOUS - T. Rowe Price International Equity ETF - Stock Price Chart
TickerTOUS [NYSE]
CompanyT. Rowe Price International Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Broad / Regional
Index-
TagsInternational, equity
Sector/Theme Region
Dividend2.61%Active/Passive
Total Holdings199AUM115.58M
Flows% 1M8.28%Flows% 3M23.98%
Flows% YTD14.33%Flows% 1Y
Return% 1Y10.38%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume93.18K52W Range25.76 - 30.70
ACLC - American Century Large Cap Equity ETF - Stock Price Chart
TickerACLC [NYSE]
CompanyAmerican Century Large Cap Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Broad Market & Size
Index-
Asset TypeEquities (Stocks)ETF TypeUS Equities
Sector/Theme Region
Dividend0.95%Active/Passive
Total Holdings101AUM203.37M
Flows% 1M0.00%Flows% 3M-6.55%
Flows% YTD-1.39%Flows% 1Y
Return% 1Y3.45%Return% 3Y0.09%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume17.51K52W Range61.49 - 73.62
GGUS - Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF - Stock Price Chart
TickerGGUS [NYSE]
CompanyGoldman Sachs MarketBeta Russell 1000 Growth Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
IndexRussell 1000 Growth 40 Act Daily Capped...
TagsU.S., equity, mid-large-cap, Russell-1000, growth
Sector/Theme Region
Dividend0.74%Active/Passive
Total Holdings384AUM265.35M
Flows% 1M1.01%Flows% 3M-15.34%
Flows% YTD-7.91%Flows% 1Y
Return% 1Y10.75%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume27.51K52W Range43.73 - 57.00
JSML - Janus Henderson Small Cap Growth Alpha ETF - Stock Price Chart
TickerJSML [NASD]
CompanyJanus Henderson Small Cap Growth Alpha ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Dividend & Fundamental
IndexJanus Henderson Small Cap Growth Alpha I...
TagsU.S., equity, growth, small-cap
Sector/Theme Region
Dividend1.30%Active/Passive
Total Holdings208AUM250.62M
Flows% 1M-1.21%Flows% 3M10.59%
Flows% YTD8.89%Flows% 1Y
Return% 1Y3.71%Return% 3Y0.04%
Return% 5Y11.45%Return% 10Y
NAV% Expense
Avg Volume39.23K52W Range55.96 - 74.37
FLAU - Franklin FTSE Australia ETF - Stock Price Chart
TickerFLAU [NYSE]
CompanyFranklin FTSE Australia ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Country Specific
IndexFTSE Australia Capped Index
TagsAustralia, equity, mid-large-cap
Sector/Theme Region
Dividend3.40%Active/Passive
Total Holdings109AUM47.48M
Flows% 1M-17.52%Flows% 3M-8.36%
Flows% YTD-8.36%Flows% 1Y
Return% 1Y1.41%Return% 3Y0.03%
Return% 5Y11.47%Return% 10Y
NAV% Expense
Avg Volume8.36K52W Range27.10 - 32.28
ARKA - ARK 21Shares Active Bitcoin Futures Strategy ETF - Stock Price Chart
TickerARKA [AMEX]
CompanyARK 21Shares Active Bitcoin Futures Strategy ETF
CountryUSA
IndustryExchange Traded Fund
CategoryOther Asset Types - Multi-Asset / Other
Index-
Tagsfutures, crypto, bitcoin, ethereum
Sector/Theme Region
Dividend32.88%Active/Passive
Total Holdings6AUM13.57M
Flows% 1M0.00%Flows% 3M1.86%
Flows% YTD-10.24%Flows% 1Y
Return% 1Y2.87%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume3.09K52W Range40.61 - 73.14
1234561020